Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 18OTHER 10NETWORK 4OTHER_GOV 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, B-Cell, Marginal Zone 1

Interventions

Surveys and Questionnaires 7Blood Specimen Collection 7Observation 6Surgical Procedures, Operative 4Radiotherapy 4Drug Therapy 4Physical Examination 3Magnetic Resonance Spectroscopy 3Endoscopic Mucosal Resection 3Echocardiography 3pembrolizumab 2Zoledronic Acid 2Watchful Waiting 2Thyroidectomy 2Standard of Care 2Robotic Surgical Procedures 2Radiosurgery 2Radiation 2Preoperative Exercise 2Population Groups 2Palliative Care 2Nivolumab 2Neoadjuvant Therapy 2Mass Screening 2Laparoscopy 2Immune Checkpoint Inhibitors 2Hematologic Tests 2Granulocyte Colony-Stimulating Factor 2Gastrectomy 2Endoscopic Ultrasound-Guided Fine Needle Aspiration 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Observational × Rituximab × Clear all
NCT07233720 2025-11-18

Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma

Henan Cancer Hospital

Recruiting
30 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡